Pesticide use and risk of non-Hodgkin lymphoid malignancies in agricultural cohorts from France, Norway and the USA: a pooled analysis from the AGRICOH consortium.


Journal

International journal of epidemiology
ISSN: 1464-3685
Titre abrégé: Int J Epidemiol
Pays: England
ID NLM: 7802871

Informations de publication

Date de publication:
01 10 2019
Historique:
accepted: 04 02 2019
pubmed: 19 3 2019
medline: 21 4 2020
entrez: 19 3 2019
Statut: ppublish

Résumé

Pesticides are commonly used in agriculture, and previous studies endorsed the need to further investigate the possible association between their use and risk of lymphoid malignancies in agricultural workers. We investigated the relationship of ever use of 14 selected pesticide chemical groups and 33 individual active chemical ingredients with non-Hodgkin lymphoid malignancies (NHL) overall or major subtypes, in a pooled analysis of three large agricultural worker cohorts. Pesticide use was derived from self-reported history of crops cultivated combined with crop-exposure matrices (France and Norway) or self-reported lifetime use of active ingredients (USA). Cox regression models were used to estimate cohort-specific hazard ratios (HRs) and 95% confidence intervals (CIs), which were combined using random effects meta-analysis to calculate meta-HRs. During follow-up, 2430 NHL cases were diagnosed in 316 270 farmers accruing 3 574 815 person-years under risk. Most meta-HRs suggested no association. Moderately elevated meta-HRs were seen for: NHL and ever use of terbufos (meta-HR = 1.18, 95% CI: 1.00-1.39); chronic lymphocytic leukaemia/small lymphocytic lymphoma and deltamethrin (1.48, 1.06-2.07); and diffuse large B-cell lymphoma and glyphosate (1.36, 1.00-1.85); as well as inverse associations of NHL with the broader groups of organochlorine insecticides (0.86, 0.74-0.99) and phenoxy herbicides (0.81, 0.67-0.98), but not with active ingredients within these groups, after adjusting for exposure to other pesticides. Associations of pesticides with NHL appear to be subtype- and chemical-specific. Non-differential exposure misclassification was an important limitation, showing the need for refinement of exposure estimates and exposure-response analyses.

Sections du résumé

BACKGROUND
Pesticides are commonly used in agriculture, and previous studies endorsed the need to further investigate the possible association between their use and risk of lymphoid malignancies in agricultural workers.
METHODS
We investigated the relationship of ever use of 14 selected pesticide chemical groups and 33 individual active chemical ingredients with non-Hodgkin lymphoid malignancies (NHL) overall or major subtypes, in a pooled analysis of three large agricultural worker cohorts. Pesticide use was derived from self-reported history of crops cultivated combined with crop-exposure matrices (France and Norway) or self-reported lifetime use of active ingredients (USA). Cox regression models were used to estimate cohort-specific hazard ratios (HRs) and 95% confidence intervals (CIs), which were combined using random effects meta-analysis to calculate meta-HRs.
RESULTS
During follow-up, 2430 NHL cases were diagnosed in 316 270 farmers accruing 3 574 815 person-years under risk. Most meta-HRs suggested no association. Moderately elevated meta-HRs were seen for: NHL and ever use of terbufos (meta-HR = 1.18, 95% CI: 1.00-1.39); chronic lymphocytic leukaemia/small lymphocytic lymphoma and deltamethrin (1.48, 1.06-2.07); and diffuse large B-cell lymphoma and glyphosate (1.36, 1.00-1.85); as well as inverse associations of NHL with the broader groups of organochlorine insecticides (0.86, 0.74-0.99) and phenoxy herbicides (0.81, 0.67-0.98), but not with active ingredients within these groups, after adjusting for exposure to other pesticides.
CONCLUSIONS
Associations of pesticides with NHL appear to be subtype- and chemical-specific. Non-differential exposure misclassification was an important limitation, showing the need for refinement of exposure estimates and exposure-response analyses.

Identifiants

pubmed: 30880337
pii: 5382278
doi: 10.1093/ije/dyz017
pmc: PMC6857760
doi:

Substances chimiques

Pesticides 0

Types de publication

Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1519-1535

Subventions

Organisme : Intramural NIH HHS
ID : Z01 CP010119
Pays : United States
Organisme : NCI NIH HHS
ID : Z01 CP010119
Pays : United States

Informations de copyright

© World Health Organization, 2019. All rights reserved. The World Health Organization has granted the Publisher permission for the reproduction of this article.

Références

IARC Monogr Eval Carcinog Risks Hum. 2012;100(Pt F):9-562
pubmed: 23189753
J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Oct 5;778(1-2):131-45
pubmed: 12376121
J Expo Sci Environ Epidemiol. 2017 Jan;27(1):56-63
pubmed: 26696463
Environ Toxicol Chem. 2002 Feb;21(2):260-8
pubmed: 11833793
Environ Health Perspect. 2016 Jun;124(6):713-21
pubmed: 26600562
Int J Environ Res Public Health. 2014 Apr 23;11(4):4449-527
pubmed: 24762670
Sci Rep. 2016 May 17;6:25768
pubmed: 27185567
Occup Environ Med. 2013 Feb;70(2):91-8
pubmed: 23117219
Occup Environ Med. 2016 Jun;73(6):359-67
pubmed: 27009271
Cancer Res. 2004 Mar 15;64(6):2264-9
pubmed: 15026372
Lancet Oncol. 2016 Dec;17(12):1637-1638
pubmed: 27784619
Toxicology. 2001 Aug 28;165(2-3):153-62
pubmed: 11522373
Scand J Work Environ Health. 1992 Aug;18(4):209-15
pubmed: 1411362
Int J Cancer. 2012 Dec 1;131(11):2650-9
pubmed: 22396152
Scand J Work Environ Health. 1998 Aug;24(4):255-61
pubmed: 9754856
J Natl Cancer Inst. 2018 May 1;110(5):509-516
pubmed: 29136183
Stat Med. 2011 Feb 20;30(4):377-99
pubmed: 21225900
Environ Health Perspect. 2005 Jan;113(1):49-54
pubmed: 15626647
PLoS One. 2014 Oct 22;9(10):e109332
pubmed: 25337994
Am Ind Hyg Assoc J. 1998 Mar;59(3):166-72
pubmed: 9530802
J Natl Cancer Inst Monogr. 2014 Aug;2014(48):130-44
pubmed: 25174034
Ann Occup Hyg. 2016 Jul;60(6):669-83
pubmed: 27109466
Ann Occup Hyg. 2009 Jan;53(1):69-81
pubmed: 19022871
J Occup Environ Med. 2001 Jul;43(7):641-9
pubmed: 11464396
J Environ Sci Health B. 2016;51(6):402-34
pubmed: 27015139
Cancer Causes Control. 2007 Dec;18(10):1209-26
pubmed: 17874193
Ann Epidemiol. 2015 Aug;25(8):626-636.e4
pubmed: 26066538
Am J Epidemiol. 1986 Apr;123(4):736-51
pubmed: 3953551
Occup Environ Med. 2009 May;66(5):291-8
pubmed: 19017688
Int J Cancer. 2008 Oct 1;123(7):1657-63
pubmed: 18623080
Cancer Res. 1992 May 1;52(9):2447-55
pubmed: 1568215
J Expo Sci Environ Epidemiol. 2012 Jul;22(4):409-16
pubmed: 22569205
Int J Environ Res Public Health. 2011 May;8(5):1341-57
pubmed: 21655123
Int J Epidemiol. 2005 Jun;34(3):680-7
pubmed: 15802377
Environ Pollut. 2017 Dec;231(Pt 1):319-328
pubmed: 28810201
J Expo Sci Environ Epidemiol. 2012 Nov;22(6):593-600
pubmed: 22892809
Int Arch Occup Environ Health. 2015 Jan;88(1):61-73
pubmed: 24599726
Cancer Res. 1994 May 1;54(9):2386-9
pubmed: 8162585
J Occup Environ Hyg. 2016;13(6):476-89
pubmed: 26853603
Blood. 2007 Jul 15;110(2):695-708
pubmed: 17389762
Cancer Causes Control. 2001 Aug;12(6):509-17
pubmed: 11519759
Scand J Work Environ Health. 1996 Feb;22(1):14-26
pubmed: 8685669
J Agromedicine. 2009;14(2):125-31
pubmed: 19437268
Int J Cancer. 2007;120 Suppl 12:1-39
pubmed: 17405121
Lancet Oncol. 2015 Aug;16(8):891-2
pubmed: 26111929
Toxicol Lett. 1999 Jun 30;107(1-3):219-24
pubmed: 10414799
J Natl Cancer Inst. 1987 May;78(5):899-910
pubmed: 3471999
Occup Environ Med. 2017 Jan;74(1):81
pubmed: 27852645
Environ Health Perspect. 2001 Aug;109(8):839-44
pubmed: 11564621
Environ Health Perspect. 1996 Apr;104(4):362-9
pubmed: 8732939

Auteurs

Maria E Leon (ME)

Section of Environment and Radiation, International Agency for Research on Cancer (IARC), Lyon, France.

Leah H Schinasi (LH)

Section of Environment and Radiation, International Agency for Research on Cancer (IARC), Lyon, France.
Department of Environmental and Occupational Health, Drexel University, Philadelphia, PA, USA.

Pierre Lebailly (P)

ANTICIPE, U1086 INSERM, Université de Caen Normandie, and Centre de Lutte Contre le Cancer François Baclesse, Caen, France.

Laura E Beane Freeman (LE)

Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), Bethesda, MD, USA.

Karl-Christian Nordby (KC)

Department of Occupational Medicine and Epidemiology, National Institute of Occupational Health (STAMI), Oslo, Norway.

Gilles Ferro (G)

Section of Environment and Radiation, International Agency for Research on Cancer (IARC), Lyon, France.

Alain Monnereau (A)

Hematological Malignancies Registry of Gironde, Bergonie Institute, Comprehensive Cancer Centre, Bordeaux, France.
University of Bordeaux, INSERM U1219 Center - EPICENE Team, CHU de Bordeaux, Bordeaux, France.

Maartje Brouwer (M)

Institute for Risk Assessment Sciences (IRAS), Utrecht University, Utrecht, The Netherlands.

Séverine Tual (S)

ANTICIPE, U1086 INSERM, Université de Caen Normandie, and Centre de Lutte Contre le Cancer François Baclesse, Caen, France.

Isabelle Baldi (I)

CHU de Bordeaux, Service de Médecine du Travail et Pathologie Professionnelle, Bordeaux, France.

Kristina Kjaerheim (K)

Department of Research, Cancer Registry of Norway, Oslo, Norway.

Jonathan N Hofmann (JN)

Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), Bethesda, MD, USA.

Petter Kristensen (P)

Department of Occupational Medicine and Epidemiology, National Institute of Occupational Health (STAMI), Oslo, Norway.

Stella Koutros (S)

Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), Bethesda, MD, USA.

Kurt Straif (K)

Section of Evidence Synthesis and Classification, International Agency for Research on Cancer (IARC), Lyon, France.

Hans Kromhout (H)

Institute for Risk Assessment Sciences (IRAS), Utrecht University, Utrecht, The Netherlands.

Joachim Schüz (J)

Section of Environment and Radiation, International Agency for Research on Cancer (IARC), Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH